AMIX
Autonomix Medical, Inc. Common Stock
NASDAQ · Healthcare · Medical - Devices · US
$4.59
−1.92%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- -37.3%
- EBIT
- -33.7%
- EPS
- +27.9%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- +33.7%
- EPS
- +52.3%
Three-year CAGR
- Revenue
- —
- EBITDA
- -54.1%
- EBIT
- -47.0%
- Net income
- -46.5%
- EPS
- +64.1%
- Free cash flow
- -48.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026